Filtros : "Financiamento NWO" "COVID-19" Removido: "Financiamento MINECO" Limpar

Filtros



Refine with date range


  • Source: Organic Letters. Unidade: IQ

    Subjects: COVID-19, ÁCIDOS NUCLEICOS

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      RIJPKEMA, Koen J et al. Synthesis of structural ADP-ribose analogues as inhibitors for SARS-CoV-2 Macrodomain 1. Organic Letters, v. 26, p. 5700−5704, 2024Tradução . . Disponível em: https://dx.doi.org/10.1021/acs.orglett.4c01792. Acesso em: 01 nov. 2024.
    • APA

      Rijpkema, K. J., Schuller, M., Veer, M. S. van der, Rieken, S., Chang, D. L. R., Balić, P., et al. (2024). Synthesis of structural ADP-ribose analogues as inhibitors for SARS-CoV-2 Macrodomain 1. Organic Letters, 26, 5700−5704. doi:10.1021/acs.orglett.4c01792
    • NLM

      Rijpkema KJ, Schuller M, Veer MS van der, Rieken S, Chang DLR, Balić P, Todorov A, Minnee H, Wijngaarden S, Matos IA, Hoch NC, Codée JDC, Ahel I, Filippov DV. Synthesis of structural ADP-ribose analogues as inhibitors for SARS-CoV-2 Macrodomain 1 [Internet]. Organic Letters. 2024 ; 26 5700−5704.[citado 2024 nov. 01 ] Available from: https://dx.doi.org/10.1021/acs.orglett.4c01792
    • Vancouver

      Rijpkema KJ, Schuller M, Veer MS van der, Rieken S, Chang DLR, Balić P, Todorov A, Minnee H, Wijngaarden S, Matos IA, Hoch NC, Codée JDC, Ahel I, Filippov DV. Synthesis of structural ADP-ribose analogues as inhibitors for SARS-CoV-2 Macrodomain 1 [Internet]. Organic Letters. 2024 ; 26 5700−5704.[citado 2024 nov. 01 ] Available from: https://dx.doi.org/10.1021/acs.orglett.4c01792
  • Source: Science. Unidades: IFSC, FCFRP

    Subjects: COVID-19, ENZIMAS, ESPECTROSCOPIA, PROTEÍNAS, PLANEJAMENTO DE FÁRMACOS, MICROSCOPIA

    PrivadoAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      BOBY, Melissa L. et al. Open science discovery of potent noncovalent SARS-CoV-2 main protease inhibitors. Science, v. 382, n. 6671, p. eabo7201-1-eabo7201-16 + supplementary materials, 2023Tradução . . Disponível em: https://doi.org/10.1126/science.abo7201. Acesso em: 01 nov. 2024.
    • APA

      Boby, M. L., Fernandes, R. S., Gawriljuk, V. O., Godoy, A. S. de, Nakamura, A. M., Noske, G. D., et al. (2023). Open science discovery of potent noncovalent SARS-CoV-2 main protease inhibitors. Science, 382( 6671), eabo7201-1-eabo7201-16 + supplementary materials. doi:10.1126/science.abo7201
    • NLM

      Boby ML, Fernandes RS, Gawriljuk VO, Godoy AS de, Nakamura AM, Noske GD, Oliva G, Rangel VL. Open science discovery of potent noncovalent SARS-CoV-2 main protease inhibitors [Internet]. Science. 2023 ; 382( 6671): eabo7201-1-eabo7201-16 + supplementary materials.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1126/science.abo7201
    • Vancouver

      Boby ML, Fernandes RS, Gawriljuk VO, Godoy AS de, Nakamura AM, Noske GD, Oliva G, Rangel VL. Open science discovery of potent noncovalent SARS-CoV-2 main protease inhibitors [Internet]. Science. 2023 ; 382( 6671): eabo7201-1-eabo7201-16 + supplementary materials.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1126/science.abo7201
  • Source: Cell Stem Cell. Unidade: IFSC

    Subjects: CORONAVIRUS, COVID-19, RIM

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      JANSEN, Jitske et al. SARS-CoV-2 infects the human kidney and drives fibrosis in kidney organoids. Cell Stem Cell, v. 29, n. 2, p. 217-231 + e1-e8, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.stem.2021.12.010. Acesso em: 01 nov. 2024.
    • APA

      Jansen, J., Fernandes, R. S., Oliveira, V. G. F., Godoy, A. S. de, Nakamura, A. M., Noske, G. D., & Oliva, G. (2022). SARS-CoV-2 infects the human kidney and drives fibrosis in kidney organoids. Cell Stem Cell, 29( 2), 217-231 + e1-e8. doi:10.1016/j.stem.2021.12.010
    • NLM

      Jansen J, Fernandes RS, Oliveira VGF, Godoy AS de, Nakamura AM, Noske GD, Oliva G. SARS-CoV-2 infects the human kidney and drives fibrosis in kidney organoids [Internet]. Cell Stem Cell. 2022 ; 29( 2): 217-231 + e1-e8.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1016/j.stem.2021.12.010
    • Vancouver

      Jansen J, Fernandes RS, Oliveira VGF, Godoy AS de, Nakamura AM, Noske GD, Oliva G. SARS-CoV-2 infects the human kidney and drives fibrosis in kidney organoids [Internet]. Cell Stem Cell. 2022 ; 29( 2): 217-231 + e1-e8.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1016/j.stem.2021.12.010
  • Source: Nature Human Behaviour. Unidade: IP

    Subjects: INTERVENÇÃO PSICOLÓGICA, ESTADOS EMOCIONAIS, PANDEMIAS, COVID-19

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      WANG, Ke e VALENTOVA, Jaroslava Varella e VARELLA, Marco Antonio Correa. A multi-country test of brief reappraisal interventions on emotions during the COVID-19 pandemic. Nature Human Behaviour, v. 5, p. 1089–111, 2021Tradução . . Disponível em: https://doi.org/10.1038/s41562-021-01173-x. Acesso em: 01 nov. 2024.
    • APA

      Wang, K., Valentova, J. V., & Varella, M. A. C. (2021). A multi-country test of brief reappraisal interventions on emotions during the COVID-19 pandemic. Nature Human Behaviour, 5, 1089–111. doi:10.1038/s41562-021-01173-x
    • NLM

      Wang K, Valentova JV, Varella MAC. A multi-country test of brief reappraisal interventions on emotions during the COVID-19 pandemic [Internet]. Nature Human Behaviour. 2021 ; 5 1089–111.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1038/s41562-021-01173-x
    • Vancouver

      Wang K, Valentova JV, Varella MAC. A multi-country test of brief reappraisal interventions on emotions during the COVID-19 pandemic [Internet]. Nature Human Behaviour. 2021 ; 5 1089–111.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1038/s41562-021-01173-x

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024